Kirkland & Ellis' team advises large multinational corporates facing high-stakes cross-border government investigations, and in compliance advisory contexts. ‘Absolute star’ Jodi Wu has noteworthy expertise regarding the anti-corruption issues facing large pharma companies with operations in China; Wu's workload includes advising clients facing internal investigations into improper sales practices, and assisting clients facing regulatory investigation brought by the Chinese authorities. Anti-corruption compliance and investigations work within the asset management sector is also an area of expertise of Wu and LA-based fellow co-head Cori Lable.
Legal 500 Editorial commentary
Accolades
Client satisfaction
Testimonials
Collated independently by Legal 500 research team.
- 'They have extensive knowledge of the pharmaceutical industry and broader Asia market.'
- 'Cori Lable and Jodi Wu have unrivalled all round experience and understanding of Asia that shows through in the useful and client focused advice they provide.'
- 'Jodi Wu is an absolute star who makes her available and truly understands the needs of her clients, especially in the pharmaceutical industry. We are lucky to have her on our side.'
- 'Jodi Wu is a strong operator in their HK office. She has deep experience in a wide range of investigative topics and approaches client situations in a balanced, professional manner.'
Work highlights
Lawyers
Leading partners
The strongest partners in their field, leading on market-leading deals and endorsed by peers and clients alike.
Practice head
Jodi Wu; Cori Lable